Cargando…
Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
SIMPLE SUMMARY: In the last twenty years, minimally invasive surgery (MIS) has radically changed the surgical landscape. In the field of thoracic surgery, approaches such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) have become the new standards fo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487098/ https://www.ncbi.nlm.nih.gov/pubmed/37686557 http://dx.doi.org/10.3390/cancers15174281 |
_version_ | 1785103157539373056 |
---|---|
author | Berzenji, Lawek Wen, Wen Verleden, Stijn Claes, Erik Yogeswaran, Suresh Krishan Lauwers, Patrick Van Schil, Paul Hendriks, Jeroen M. H. |
author_facet | Berzenji, Lawek Wen, Wen Verleden, Stijn Claes, Erik Yogeswaran, Suresh Krishan Lauwers, Patrick Van Schil, Paul Hendriks, Jeroen M. H. |
author_sort | Berzenji, Lawek |
collection | PubMed |
description | SIMPLE SUMMARY: In the last twenty years, minimally invasive surgery (MIS) has radically changed the surgical landscape. In the field of thoracic surgery, approaches such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) have become the new standards for the majority of procedures performed, especially for early-stage lung cancer. Despite these developments, there is still a lack of concrete data regarding treatment outcomes of these minimally invasive approaches compared to the conventional open surgery. In the future, the number of minimally invasive procedures will likely keep increasing as more lung cancer nodules are detected at early stages due to lung cancer screening initiatives. Therefore, data on short- and long-term outcomes of VATS and RATS in early-stage lung cancer is needed. ABSTRACT: In the last two decades, robotic-assisted thoracoscopic surgery (RATS) has gained popularity as a minimally invasive surgical (MIS) alternative to multi- and uniportal video-assisted thoracoscopic surgery (VATS). With this approach, the surgeon obviates the known drawbacks of conventional MIS, such as the reduced in-depth perception, hand-eye coordination, and freedom of motion of the instruments. Previous studies have shown that a robotic approach for operable lung cancer has treatment outcomes comparable to other MIS techniques such as multi-and uniportal VATS, but with less blood loss, a lower conversion rate to open surgery, better lymph node dissection rates, and improved ergonomics for the surgeon. The thoracic surgeon of the future is expected to perform more complex procedures. More patients will enter a multimodal treatment scheme making surgery more difficult due to severe inflammation. Furthermore, due to lung cancer screening programs, the number of patients presenting with operable smaller lung nodules in the periphery of the lung will increase. This, combined with the fact that segmentectomy is becoming an increasingly popular treatment for small peripheral lung lesions, indicates that the future thoracic surgeons need to have profound knowledge of segmental resections. New imaging techniques will help them to locate these lesions and to achieve a complete oncologic resection. Current robotic techniques exist to help the thoracic surgeon overcome these challenges. In this review, an update of the latest MIS approaches and nodule detection techniques will be given. |
format | Online Article Text |
id | pubmed-10487098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104870982023-09-09 Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand? Berzenji, Lawek Wen, Wen Verleden, Stijn Claes, Erik Yogeswaran, Suresh Krishan Lauwers, Patrick Van Schil, Paul Hendriks, Jeroen M. H. Cancers (Basel) Review SIMPLE SUMMARY: In the last twenty years, minimally invasive surgery (MIS) has radically changed the surgical landscape. In the field of thoracic surgery, approaches such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS) have become the new standards for the majority of procedures performed, especially for early-stage lung cancer. Despite these developments, there is still a lack of concrete data regarding treatment outcomes of these minimally invasive approaches compared to the conventional open surgery. In the future, the number of minimally invasive procedures will likely keep increasing as more lung cancer nodules are detected at early stages due to lung cancer screening initiatives. Therefore, data on short- and long-term outcomes of VATS and RATS in early-stage lung cancer is needed. ABSTRACT: In the last two decades, robotic-assisted thoracoscopic surgery (RATS) has gained popularity as a minimally invasive surgical (MIS) alternative to multi- and uniportal video-assisted thoracoscopic surgery (VATS). With this approach, the surgeon obviates the known drawbacks of conventional MIS, such as the reduced in-depth perception, hand-eye coordination, and freedom of motion of the instruments. Previous studies have shown that a robotic approach for operable lung cancer has treatment outcomes comparable to other MIS techniques such as multi-and uniportal VATS, but with less blood loss, a lower conversion rate to open surgery, better lymph node dissection rates, and improved ergonomics for the surgeon. The thoracic surgeon of the future is expected to perform more complex procedures. More patients will enter a multimodal treatment scheme making surgery more difficult due to severe inflammation. Furthermore, due to lung cancer screening programs, the number of patients presenting with operable smaller lung nodules in the periphery of the lung will increase. This, combined with the fact that segmentectomy is becoming an increasingly popular treatment for small peripheral lung lesions, indicates that the future thoracic surgeons need to have profound knowledge of segmental resections. New imaging techniques will help them to locate these lesions and to achieve a complete oncologic resection. Current robotic techniques exist to help the thoracic surgeon overcome these challenges. In this review, an update of the latest MIS approaches and nodule detection techniques will be given. MDPI 2023-08-26 /pmc/articles/PMC10487098/ /pubmed/37686557 http://dx.doi.org/10.3390/cancers15174281 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Berzenji, Lawek Wen, Wen Verleden, Stijn Claes, Erik Yogeswaran, Suresh Krishan Lauwers, Patrick Van Schil, Paul Hendriks, Jeroen M. H. Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand? |
title | Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand? |
title_full | Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand? |
title_fullStr | Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand? |
title_full_unstemmed | Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand? |
title_short | Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand? |
title_sort | minimally invasive surgery in non-small cell lung cancer: where do we stand? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487098/ https://www.ncbi.nlm.nih.gov/pubmed/37686557 http://dx.doi.org/10.3390/cancers15174281 |
work_keys_str_mv | AT berzenjilawek minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand AT wenwen minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand AT verledenstijn minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand AT claeserik minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand AT yogeswaransureshkrishan minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand AT lauwerspatrick minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand AT vanschilpaul minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand AT hendriksjeroenmh minimallyinvasivesurgeryinnonsmallcelllungcancerwheredowestand |